SCIENTIFIC PUBLICATIONS (per 01.06.2004)
Articles in Books: 45
Articles in International Journals: 370
Articles in National Journals: 29
PRIZES
- Prize Divry of the Belgian Society of Neurology,
Brussels, Belgium, October 21, 1991: 'Gene technology and Alzheimer
disease'.
- Co-recipient of the Potamkin Prize of the American
Academy of Neurology, New York, USA, April 27, 1993: 'APP mutations
and cerebral haemorrhages'.
- Scientific Prize Joseph Maisin of the National
Fund of Scientific Research (NFSR), Brussels, Belgium, July 5,
1995: Medical and Biological Sciences ‘Molecular Genetics
of Alzheimer disease: Identification of genes and gene mutations’.
- Prize Marie-Thérèse De Lava,
of the King Boudewijn Foundation, Brussels, Belgium, November
21, 1995: Ageing ‘Molecular Genetics of Alzheimer Disease'.
- Co-recipient of the Scientific Prize Upjohn Inc.
of the National Fund for Scientific Research (NFSR), Brussels,
Belgium, December 18, 1995 ‘Molecular genetic research of
neurodegenerative disorders: peripheral neuropathy of Charcot-Marie-Tooth
disesase (CMT type 1)’.
- Co-recipient of the Lundbeck-Prize of the Belgian
College of Neuropsychopharmacology and Biological Psychiatry (BCNBP),
Brussels, Belgium, June 3, 1997: The presenilin genes: A new family
involved in Alzheimer disease pathology’.
- Special Honor Award for Women in Science 2002,
with the support of L’Oréal/Unesco, Brussels, Belgium,
January 23, 2003
HONORS
- Alzheimer Professor Chair, University of Leiden,
Department of Neurology 1996
- Associate Member of the Royal Flemish Academy
of Sciences and Art - Belgium, 1999
- Guest Scientist at The Scripps Research Institute
La Jolla, San Diego, USA, 2001
PROFESSIONAL SOCIETY ACTIVITIES
International
Current Activities
European Charcot-Marie-Tooth Consortium: Consortium Leader and President
of the Steering Committee, 1991
Federation of the European Neurological Societies (FENS): Scientific
Panel on ‘Genetics, including Molecular Genetics’, 1993
EU – Expert Group on Women in Science, Life Sciences, 2002
European College of Neuropsychopharmacology (ECNP), Member of the
Scientific Advisory Panel ‘Degenerative Disorders’,
2003
EU – Evaluator – VI frame work, 2002-2006
EU – Evaluation Panel – EU program on ‘Life Sciences:
Genomics and Biotechnology for Health’ – Area ‘Fundamental
Genomics’, 2004
EU – European Research Advisory Board (EURAB), Member, 2004
- 2007
Human Frontier Science Program (HFSP), Council of Scientists 2001
The International Society of Psychiatric Genetics: Board, 1994
The International Society of Psychiatric Genetics: International
Scientific Programme Committee, 1996, 1998, 1999, 2001, 2002
The International Society of Psychiatric Genetics: Vice President,
2000
The International Society of Psychiatric Genetics: Chair & Local
Organiser Xth World Congress on Psychiatric Genetics, 2002, 2003,
2004
USA, Faculty of 1000 Medicine: Faculty member and member of the
Evaluation Board, Section Head ‘Alzheimer’s disease’,
2004
USA, Alzheimer Research Forum, Member of the Scientific Advisory
Board, 2004
USA, Mayo Clinic Jacksonville, Program Project ‘Genetic and
functional studies to determine the role of tau in PSP’, Member
of the External Advisory Board, 2004
Past Activities
European Society of Human Genetics: Board, 1992-1997
European Society of Human Genetics: Chairperson of the Scientific
Programming Committee, 1993-1994
European Society of Human Genetics: Scientific Programming Committee,
1993-1997
European Neuro-Muscular Centre (ENMC): Research Committee, 1994-1999
EU – Concerted Action on ‘Cellular Aging and Disease’
(EURAGE): Biology of Aging Group, 1989-1991
EU – BIOMED2 Ad Hoc Working Group on Human Genome Research,
1995-1996
EU – Evaluation panel – EU Projects Human Genome Analysis,
1996
EU – Evaluator – IV frame work – BIOMED2 programme,
2nd Call, 1996-1998
EU – Evaluation Panel – EU Training and Mobility of
Researchers – Life Sciences, 1997
EU – National Contact Person of BIOMED2 on ‘Ageing’
for the Ad hoc Advisory Committee (AHAC) to CREST for the co-ordination
of RTD Policies, 1998
EU – Evaluator – V frame work, 1999-2000
EU – High Level Expert Group I on Chronic and degenerative
diseases, genomics, neurosciences, 1999-2003
EU – Expert for the Assessment of Expressions of Interest
(EoI’s) ‘Studying the brain and combating diseases of
the nervous system’, 2002
Human Genome Organisation (HUGO): Community Editor of chromosome
21, 1993-1998
The International Society of Psychiatric Genetics: International
Advisory Committee, 1993
Alzheimer’s Disease and Related Disorders: International Advisory
Committee, 1994
Alzheimer’s Disease and Related Disorders: Scientific Programme
Committee, 1997-1998
USA - Charcot-Marie-Tooth Association (CMTA): Medical Board, 1998-2004
National
Current Activities
Born-Bunge Foundation (BBS): Scientific Advisory Board, 1990
Flanders Interuniversity Institute for Biotechnology (VIB): Board
of Scientific Directors, 1995
Flemish Institute for the advancement of Scientific and Technological
Research in Industry (IWT): Evaluator of the PhD & Postdoc fellowships,
1995
Fund for Scientific Research – Flanders (FWO): Commission
Medical Cell Biology and Genetics 1997 – 2006
Flemish Board of Scientific Policy (VRWB): Member, 2000-2002
National Fund for Scientific Research (NFSR): Working party 'Ethical
genetics', 1994
Federal Ministry of Science Policy, Member of the High Level Group
3% for Research, 2004
Alzheimer Liga Belgium: Scientific Advisory Board, 1990
CMT-Belgium: Scientific Advisory Board, 1991
Medical Women's Association of Belgium: Board, 1995
Belgian College of Neuropsychopharmacology and Biological Psychiatry:
Councillor, 2000
King Boudewijn Foundation – Workgroup Human Genome, 2001
International Alzheimer Research Foundation (IARF): Member of the
Scientific Advisory Board, 1996
International Alzheimer Research Foundation (IARF): Chair, 2003
Finland – Academy of Finland, Research Council for Health:
Scientific Expert, 2002
Germany - German Ministry for Science – Kompetenznetzwerk
‘Mednet Stroke’: Advisory Board, 1999
Germany - National Medical Network on Dementias by the German Federal
Ministry of Education and Research (BMBF): International Advisory
Board, 2000
Germany - Max-Delbrück-Center for Molecular Medicine, Berlin:
Member of the Expert group, 2001
Italy - Italian Téléthon Foundation: Scientific Committee,
2001
Sweden - Center for Molecular Medicine, Karolinska Institute: Advisory
Board, 1996
The Netherlands: Netherlands Organisation for Scientific Research
(NWO) – Human Genome Analysis’: Evaluation Committee,
1997
The Netherlands: Netherlands Organisation for Scientific Research
(NWO) – The Research Institute ‘Diseases of the elderly’:
International Expert Committee, 1999
UK – Alzheimer Research Charity: Charity Trustee, 1998
Past Activities
Provincial Centre for the Detection of Metabolic diseases: Steering
Group, 1990-1993
Institute for Scientific Research in Industry and Agriculture (IWONL),
Evaluator of fellowships, 1991-1993
Belgian Society for Neurology: Jury Member Divry, 1994
Belgian Society of Biochemistry and Molecular Biology: Board Member,
1996-1999
Administration for Science and Innovation (AWI), Jury Member of
the Commission, 1999
The Royal Academy of Medicine – Belgium, Jury Member for the
Prize of the Flemish Scientific Foundation for Biomedical Sciences
2004
MILQTL-programme: Review Panel, 1994 – 1998
Germany - 11.Jahrestagung der Deutschen Gesellschaft für Humangenetik:
Scientific Programme Committee, 1998 – 1999
Germany - National Network on genomic research – area neurological
/ neuropsychiatric diseases by the German Federal Ministry of Education
and Research (BMBF): Reviewing Board, 2001
The Netherlands - Internationale Stichting Alzheimer Onderzoek (ISAO):
Scientific Advisory Board, 1995-1997
The Netherlands – Ministry of Public Health: Gezondheidsraad:
Commission DNA-Diagnostics, 1995 – 1998
UK – Alzheimer’s Research Trust: Scientific Advisory
Board, 1993-1997
PROFESSIONAL MEMBERSHIPS
International
European Neuroscience Association, 1991
European Society of Human Genetics, 1991
Federation of European Neuroscience Societies, 1996
American Association for the Advancement of Science, 1991
Society for Neuroscience, 1990
The American Society of Human Genetics, 1987
The International Society of Psychiatric Genetics, 1992
National
Belgian Society of Biochemistry, 1988
Belgian Society for Cell Biology, 1994
Belgian Society of Neurology, 1990
Belgian Society for Neuroscience, 1996
Belgian College of Neuropsychopharmacology and Biological Psychiatry,
2000
Belgian Society for Human Genetics, 2002
Stichting Lieve Nijs vzw: Leven met dementia, 1993
The Society for Forensic Haemogenetics, 1988-1989
GRANTS
Supervisor
Special Research Fund – UA/UIA
Emerging Technology Centre (VLAB)
Flanders Interuniversity Institute for Biotechnology (VIB)
Fund for Medical Scientific Research (FGWO)
Fund for Scientific Research – Flanders (FWO)
National Fund for Scientific Research (NFWO)
Ministry of the Flemish Community - Education- Concerted Action
(GOA)
Ministry for Programming Scientific Policy (DPWB)
The Federal Office for Scientific, Technical and Cultural Affairs
(DWTC)
Medical Foundation Queen Elisabeth (GSKE)
International Alzheimer Research Foundation (IARF)
Innogenetics
Janssen Research Foundation (JRF)
Association Française contre les Myopathies (AFM)
European Science Foundation (ESF)
Commission of the European Communities (EEC)
American Health Assistance Foundation (AHAF)
Muscular Dystrophy Association, USA (MDA)
Focused Giving Programme, Johnson & Johnson
Alzheimer Association (AA)
Co-supervisor
Fund for Collective Scientific Research (FKFO)
Netherlands Organization for Scientific Research (NWO)
Hersenstichting Nederland
Internationale Stichting Alzheimer Onderzoek (ISAO)
Alzheimer Association (AA)
PATENTS
European
• European Patent Application EP 91/401220.8 Patent: 'Process
for the in vitro diagnosis of chromosomal anomalies liable to be
correlated with CMT1a disease', Date of Filing: 7.5.1991, Applicant:
Innogenetics, Inventors: Van Broeckhoven, C., Raeymaekers,
P., De Jonghe, P., Martin, J-J.
• European Patent Application EP 92/400771.9 Patent: 'Mutated
form of the beta-amyloid precursor protein gene', Date of Filing:
20.3.1992, Applicant: Innogenetics, Inventors: Van Broeckhoven,
C., Martin, J-J., Hendriks, L., Cras, P.
• European Patent Application EP 97/268.04.9, Patent: ‘Mood
disorder gene’, Date of Filing: 18.12.1997, Applicant: Flanders
Interuniversity Institute for Biotechnology (VIB), Inventors: Del-Favero,
J., Raeymaekers P., Van Broeckhoven, C.
• European Patent Application EP 00/202362.0, Patent: ‘
A novel APP mutation associated with an unusual Alzheimer’s
disease pathology’, Date of Filing: 06.07.2000, Applicant:
Flanders Interuniversity Institute for Biotechnology (VIB), Inventors:
Kumar-Singh, S., De Jonghe, C., Cruts, M., Van Broeckhoven, C.
• European Patent Application EP 01/203558.0, Patent: ‘Novel
brain expressed CAP-2 gene and protein associated with bipolar disorder’,
Date of Filing: 17.09.2001, Applicant: Janssen Pharmaceutics, Inventors:
Del-Favero, J. & Van Broeckhoven, C.
• European Patent Application EP 01/202214.1, Patent: ‘Novel
brain expressed NCAG1 gene and protein associated with bipolar disorder’,
Date of Filing: 11.06.2001, Applicant: Janssen Pharmaceutics, Inventors:
Del-Favero, J. & Van Broeckhoven, C.
• European Patent Application EP 02/077724.9, Patent: ‘Diagnostic
test for the detection of peripheral Neuropathy’, Date of
Filing 09.07.2002, Applicant: Flanders Interuniversity Institute
for Biotechnology (VIB), Inventors: C. Van Broeckhoven, V. Timmerman
& P. De Jonghe
• European Patent Application EP 03076033.4 (second priority),
Patent: ‘Diagnostic test for the detection of peripheral Neuropathy’,
Date of Filing 08.04.2003, Applicant: Flanders Interuniversity Institute
for Biotechnology (VIB), Inventors: C. Van Broeckhoven, V. Timmerman
& P. De Jonghe
• European Patent Application EP 03104181.7, Patent: ‘Diagnostic
tests for the detection of motor neuropathy’, Date of Filing
13.11.03, Applicant: Interuniversity Institute for Biotechnology
(VIB), Inventors: Van Broeckhoven, C., Timmerman, V., De Jonghe,
P. & Irobi, J.
• European Patent Application EP 04102066.0, Patent: ‘Diagnostics
based on a dementia-causing gene’, Date of Filing 12.05.2004,
Applicant: Flanders Interuniversity Institute for Biotechnology
(VIB), Inventors: R. Rademakers, M. Cruts &C. Van Broeckhoven
• European Patent Application EP 04102088.4, Patent: ‘Diagnostics
based on an epilepsy causing gene’, Date of Filing 13.05.2004,
Applicant: Flanders Interuniversity Institute for Biotechnology
(VIB), Inventors: L. Claes, P. De Jonghe & C. Van Broeckhoven
International
• US Patent Application 08/133.248, Patent: 'Mutated form
of the beta-amyloid precursor protein gene', Date of Filing: 08.10.1993,
Applicant: Innogenetics, Inventors: Van Broeckhoven,
C., Martin, J-J., Hendriks, L., Cras, P.
• International Patent Application PCT/EP 98/08543, Patent:
‘Mood disorder gene’, Date of Filing: 17.12.1998, Applicant:
Flanders Interuniversity Institute for Biotechnology (VIB), Inventors:
Del-Favero, J., Raeymaekers, P.,Van Broeckhoven, C.
• International Patent Application PCT/EP 99/04106, Patent:
'Novel fragmentation vectors and uses thereof', Date of Filing:
11.06.1999, Applicant: Flanders Interuniversity Institute for Biotechnology
(VIB), Inventors: Del-Favero, J., Van Broeckhoven, C.
• International Patent Application PCT/EP01/07830, Patent:
A novel APP mutation associated with an unusual Alzheimer’s
disease pathology’, Date of Filing 06.07.2001, Applicant:
Interuniversity Institute for Biotechnology (VIB), Inventors: Kumar-Singh,
S., De Jonghe, C., Cruts, M., Van Broeckhoven, C.
• International Patent Application JAB1746-PCT, Patent: ‘Novel
brain expressed gene and protein associated with bipolar disorder’,
Date of Filing 17.09.02, Applicant: Janssen Pharmaceutics, Inventors:
Del-Favero, J. & Van Broeckhoven, C.
• International Patent Application PCT/EP03/50290, Patent:
‘Diagnostic test for the detection of peripheral Neuropathy’,
Date of Filing 08.07.03, Applicant: Interuniversity Institute for
Biotechnology (VIB), Inventors: Van Broeckhoven, C., De Jonghe,
P., Timmerman, V. & Verhoeven, K.
• US & CA Patent Application PCT/EP02/10667, Patent: ‘Brain
expressed CAP-2 gene and protein associated with bipolar Disorder’,
Date of Filing 15.01.04, Applicant: Janssen Pharmaceutica, Inventors:
Del-Favero, J. & Van Broeckhoven, C.
• Published Patent WO 2004/005541, Patent: ‘Diagnostic
test for the detection of peripheral Neuropathy’, Date of
Filing 15.01.04, Applicant: Interuniversity Institute for Biotechnology
(VIB), Inventors: Van Broeckhoven, C., De Jonghe, P., Timmerman,
V. & Verhoeven, K.
GRANT REVIEWER
National Health and Medical Research Council, Australia
Fonds zur Förderung der Wissenschaflichen Forschung, Austria
Alzheimer Association, Canada
Colciencias, Colombia
Alzheimer Forschung Initiative (AFI), Germany
The Health Research Board, Ireland
The Israel Science Foundation, Israel
The Italian Ministry for University and Scientific Research, Italy
The National Research Council, Portugal
Swiss National Science Foundation, Switzerland
Internationale Stichting Alzheimer Onderzoek (ISAO), The Netherlands
Netherlands organization for Scientific Research (NWO), The Netherlands
Action Research, UK
Medical Research Council (MRC), UK
The Muscular Dystrophy Group, UK
The Welcome Trust, UK
Alzheimer Association, USA
Human Frontier Science Program
EDITORIAL BOARDS
International
American Journal of Alzheimer’s disease: Member of the Research
Editorial Board
European Journal of Human Genetics: Member of the Editorial Board
Genes, Brain and Behavior: Member of the Editorial Board
Human Genetics: Member of the Editorial Board
Human Molecular Genetics: Member of the Editorial Board
Human Mutation: Communicating Editor
Neurobiology of Disease: Member of the Editorial Board
Neurodegenerative Diseases: Member of the Editorial Board
Neurogenetics: Member of the Editorial Board
NeuroMolecular Medicine: Co-Editor
National
Acta Neurologica Belgica: Member of the Advisory Board
Mediator plus ultra, Scientific Advisory Board
Neurowetenschappen: Member of the Scientific Advisory Board
KEY REFERENCES
Lambrechts,D., Storkebaum,E., Morimoto,M., Del-Favero,J.,
Desmet,F., Thijs,V., Wyns,S., Marklund,S.L., Andersson,J., van Marion,I.,
Al-Chalabi,A., Bornes,S., Musson,R., Hansen,V., Beckman,L., Adolfsson,R.,
Singh Pall,H., Prats,H., Rutgeerts,P., Awata,T., Scambler,P., Leigh,N.,
Lang-Lazdunski,L., Shaw,C., Moons,L., Vlietinck,R., Morrison,K.E.,
Robberecht,W., Van Broeckhoven,C., Collen,D., Andersen,P.M.,
Carmeliet,P.: VEGF is a modifier of amyotrophic lateral sclerosis
in mice and humans, and protects motor neurons against ischemic
death. Nature Genetics 34(4): 383-394 (2003) (I.F.: 26.711)
Segurado,R., Detera-Wadleigh,S.D., Levinson,D.F., Lewis,C.M., Gill,M.,
Nurnberger,Jr, Craddock,N., DePaulo,J.R., Baron,M., Gershon,E.S.,
Ekholm,J., Cichon,S., Turecki,S., Claes,S., Kelsoe,J.R., Schofield,P.R.,
Badenhop,R.F., Morissette,J., Coon,H., Blackwood,D., Curtis,D.,
McInnes,L.A., Foroud,T., Edenberg,H., Reich,T., Rice,J., Goate,A.,
McInnis,M., McMahon,F.J., Badner,J.A., Goldin,L.R., Phil Bennett,P.,
Willour,V., Zandi,P., Liu,J., Gilliam,C., Juo,S-H., Berrettini,W.H.,
Yoshikawa,T., Peltonen,L., Lönnqvist,J., Nöthen,M.M.,
Schumacher,J., Windemuth,C., Rietschel,M., Propping,P., Alda,M.,
Grof,P., Rouleau,G.A., Del-Favero,J., Van Broeckhoven,C.,
Mendlewicz,J., Adolfsson,R., Spence,M.A., Luebbert,H., Adams,L.J.,
Donald,J.A., Mitchell,P.B., Barden,N., Shink,E., Byerley,W., Muir,W.,
Visscher,P., Macgregor,S., Gurling,H., Kalsi,G., McQuillan,A., Escamilla,M.A.,
Reus,V.I., Leon,P., Freimer,N.B., Ewald,H., Kruse,T.A., Mors,O.,
Radhakrishna,U., Blouin,J.-L., Antonarakis,S.E., Akarsu,N.: Genome
Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III:
Bipolar Disorder. American Journal of Human Genetics 73(1): 49-62
(2003) (I.F.: 10.649)
Dermaut,B., Theuns,J., Sleegers,K., Hasegawa,H., Van den Broeck,M.,
Vennekens,K., Corsmit,E., St. George-Hyslop,P., Cruts,M., van Duijn,C.M.,
Van Broeckhoven,C.: The gene encoding nicastrin,
a major ?-secretase component, modifies risk for familial early-onset
Alzheimer's disease in a Dutch population-based sample. American
Journal of Human Genetics 70: 1568-1574 (2002) (I.F.: 10.649)
Van Goethem,G., Dermaut,B., Löfgren,A., Martin,J-J., Van
Broeckhoven,C.: Mutation of POLG is associated with progressive
external ophthalmplegia characterized by mtDNA deletions. Nature
Genetics 28: 211-212 (2001) (I.F.: 29.6)
Claes,L., Del-Favero,J., Ceulemans,B., Lagae,L., Van Broeckhoven,C.,
De Jonghe,P.: De novo mutations in the sodium-channel gene SCN1A
cause severe myoclonic epilepsy of infancy. American Journal of
Human Genetics 68: 1327-1332 (2001) (I.F.: 10.542)
Timmerman,V., De Jonghe,P., Van Broeckhoven,C.:
Of giant axons and curly hair. Nature Genetics 26: 254-255 (2000)
(I.F.: 30.91)
Croes,E.A., Dermaut,B., van der Cammen,T.J.M., Van Broeckhoven,C.,
van Duijn,C.M.: Genetic testing should not be advocated as a diagnostic
tool in familial forms of dementia. American Journal of Human Genetics
67: 1033-1035 (2000) (I.F.: 10.35)
Dermaut,B., Cruts,M., Slooter,A.J.C., Van Gestel,S., De Jonghe,C.,
Vanderstichele,H., Vanmechelen,E., Breteler,M.M., Hofman,A., van
Duijn,C.M., Van Broeckhoven,C.: The Glu318Gly substitution
in presenilin 1 is not causally related to Alzheimer disease. The
American Journal of Human Genetics 64: 290-292 (1999) (I.F.: 10.426)
Ott,A., Slooter,A.J.C., Hofman,A., van Harskamp,F., Witteman,J.C.M.,
Van Broeckhoven,C., van Duijn,C.M., Breteler,M.M.B.:
Smoking and risk of dementia and Alzheimer’s disease in a
population-based cohort study: the Rotterdam study. The Lancet 351:
1840-1843 (1998) (I.F.: 11.793)
Klaver,C.C.W., Kliffen,M., van Duijn,C.M., Hofman,A., Cruts,M.,
Grobbee,D.E., Van Broeckhoven,C., de Jong,P.T.V.M.:
Genetic association of apolipoprotein E with age-related macular
degeneration. American Journal of Human Genetics 63: 200-206 (1998)
(I.F.: 10.869)
Reiter,L.T., Hastings,P.J., Nelis,E., De Jonghe,P., Van
Broeckhoven,C., Lupski,J.R.: Human meiotic recombination
products revealed by sequencing a hotspot for homologous strand
exchange in multiple HNPP deletion patients. American Journal of
Human Genetics 62: 1023-1033 (1998) (I.F.: 10.869)
Tysoe,C., Whittaker,J., Xuereb,J., Cairns,N.J., Cruts,M., Van
Broeckhoven,C., Wilcock,G., Rubinsztein,D.C.: A presenilin-1
truncating mutation is present in two cases with autopsy-confirmed
early-onset Alzheimer’s disease. American Journal of Human
genetics 62: 70-76 (1998) (I.F.: 10.869)
Nelis,E., Holmberg,B., Adolfsson,R., Holmgren,G., Van Broeckhoven,C.:
PMP22 Thr(118)Met: recessive CMT1 mutation or polymorphism? Nature
Genetics 15: 13-14 (1997) (I.F.: 38.856)
Hofman,A., Ott,A., Breteler,M.M.B., Bots,M.L., Slooter,A.J.C., van
Harskamp,F., van Duijn,C.M., Van Broeckhoven,C.,
Grobbee,D.E.: Atherosclerosis, apolipoprotein E and the prevalence
of dementia and Alzheimer’s disease in the Rotterdam Study.
The Lancet 349: 151-154 (1997) (I.F.: 16.135)
Oruc,L., Lindblad,K., Verheyen,G.R., Ahlberg,S., Jakovljevic,M.,
Ivezic,S., Raeymaekers,P., Van Broeckhoven,C.,
Schalling,M.: CAG repeat expansion in bipolar and unipolar disorders.
American Journal of Human Genetics 60: 730-732 (1997) (I.F.: 10.244)
Slooter,A.J.C., Breteler,M.M., Ott,A., Van Broeckhoven,C.,
van Duijn,C.M.: APOE genotyping in differential diagnosis of Alzheimer’s
disease. The Lancet 348: 334 (1996) (I.F.: 17.948)
Warner,L.E., Hilz,M.J., Appel,S.H., Killian,J.M., Kolodny,E.H.,
Karpati,G., Carpenter,S., Watters,G.V., Wheeler,C., Witt,D., Bodell,A.,
Nelis,E., Van Broeckhoven,C., Lupski,J.R.: Clinical
phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth
type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron
17(3): 451-460 (1996) (I.F.: 16.953)
Van Broeckhoven,C.: Presinilins and Alzheimer disease.
Nature Genetics 11: 230-232 (1995) (I.F.: 28.543)
Benomar,A., Krols,L., Stevanin,G., Cancel,G., LeGuern,E., David,G.,
Ouhabi,H., Martin,J-J., Dürr,A., Zaim,M., Ravisé,N.,
Busque,C., Penet,C., Van Regemorter,N., Weissenbach,J., Yahyaoui,M.,
Chkili,T., Agid,Y., Van Broeckhoven,C., Brice,A.:
The gene for autosomal dominant cerebellar ataxia with pigmentary
macular dystrophy maps to chromosome 3p12-p21.1. Nature Genetics
10: 84-88 (1995) (I.F.: 28.543)
van Duijn,C., Van Broeckhoven,C.: Alzheimer's disease
and the family effect. Nature Genetics 8: 115 (1994) (I.F.: 22.568)
van Duijn,C.M., de Knijff,P., Cruts,M., Wehnert,A., Havekes,L.M.,
Hofman,A., Van Broeckhoven,C.: Apolipoprotein E4
allele in a population-based study of early-onset Alzheimer's disease.
Nature Genetics 7: 74-78 (1994) (I.F.: 22.568)
Kempenaers,B., Verheyen,G.R., Van den Broeck,M., Burke,T., Van
Broeckhoven,C., Dhondt,A.A.: Extra-pair paternity results
from female preference for high-quality males in the blue tit. Nature
357: 494-496 (1992) (I.F.: 25.466)
Van Broeckhoven,C., Backhovens,H., Cruts,M., De
Winter,G., Bruyland,M., Cras,P., Martin,J-J.: Mapping of a gene
predisposing to early-onset Alzheimer's disease to chromosome 14q24.3.
Nature Genetics 2: 335-339 (1992) (I.F.: 22.568)
Timmerman,V., Nelis,E., Van Hul,W., Nieuwenhuijsen,B.W., Chen,K.L.,
Wang,S., Ben Othman,K., Cullen,B., Leach,R.J., Hanemann,C.O., De
Jonghe,P., Raeymaekers,P., Van Ommen,G.J.B., Martin,J-J., Müller,H.W.,
Vance,J.M., Fischbeck,K.H., Van Broeckhoven,C.:
The peripheral myelin protein gene PMP-22 is contained within the
Charcot-Marie-Tooth disease type 1A duplication. Nature Genetics
1: 171-175 (1992) (I.F.: 22.568)
Hendriks,L., van Duijn,C.M., Cras,P., Cruts,M., Van Hul,W., van
Harskamp,F., Warren,A., McInnis,M.G., Antonarakis,S.E., Martin,J-J.,
Hofman,A., Van Broeckhoven,C.: Presenile dementia
and cerebral haemorrhage linked to a mutation at codon 692 of the
?-amyloid precursor protein gene. Nature Genetics 1: 218-221 (1992)
(I.F.: 22.568)
Hoogendijk,J.E., Hensels,G.W., Gabreëls-Festen,A.A.W.M., Gabreëls,F.J.M.,
Janssen,E.A.M., De Jonghe,P., Martin,J-J., Van Broeckhoven,C.,
Valentijn,L.J., Baas,F., De Visser,M., Bolhuis,P.A.: De-novo mutation
in hereditary motor and sensory neuropathy type I. The Lancet 339:
1081-1082 (1992) (I.F.: 17.332)
van Duijn,C.M., Hendriks,L., Cruts,M., Hardy,J.A., Hofman,A., Van
Broeckhoven,C.: Amyloid precursor protein gene mutation
in early-onset Alzheimer's disease. The Lancet 337: 978 (1991) (I.F.:
17.332)
St. George-Hyslop,P.H., Haines,J.L., Farrer,L.A., Polinsky,R.,
Van Broeckhoven,C., Goate,A., Crapper McLachlan,D.R., Orr,H.,
Bruni,A.C., Sorbi,S., Rainero,I., Foncin,J.-F., Pollen,D., Cantu,M.,
Tupler,R., Voskresenskaya,N., Mayeux,R., Growdon,J., Fried,V.A.,
Meyers,R.H., Nee,L., Backhovens,H., Martin,J-J., Rossor,M., Owen,M.J.,
Mullan,M., Percy,M.E., Karlinsky,H., Rich,S., Heston,L., Montesi,M.,
Mortilla,M., Nacmias,N., Gusella,J.F., Hardy,J.A.: Genetic linkage
studies suggest that Alzheimer's disease is not a single homogeneous
disorder. Nature: 194-197 (1990) (I.F.: 25.466)
Van Broeckhoven,C., Haan,J., Bakker,E., Hardy,J.A.,
Van Hul,W., Wehnert,A., Vegter-Van der Vlis,M., Roos,R.A.C.: Amyloid
?-protein precursor gene and hereditary cerebral hemorrhage with
amyloidosis (Dutch). Science 248: 1120-1122 (1990) (I.F.: 22.067)
Bakker,E., Van Broeckhoven,C., Bonten,E.J., van
de Vooren,M.J., Veenema,H., Van Hul,W., Van Ommen,G.J.B., Vandenberghe,A.,
Pearson,P.L.: Germline mosaicism and Duchenne muscular dystrophy
mutations. Nature : 554-556 (1987) (I.F.: 25.466)
Van Broeckhoven,C., Genthe,A.M., Vandenberghe,A.,
Horsthemke,B., Backhovens,H., Raeymaekers,P., Van Hul,W., Wehnert,A.,
Gheuens,J., Cras,P., Bruyland,M., Martin,J-J., Salbaum,M., Multhaup,G.,
Masters,C.L., Beyreuther,K., Gurling,H.M.D., Mullan,M.J., Holland,A.,
Barton,A., Irving,N., Williamson,R., Richards,S.-J., Hardy,J.: Failure
of familial Alzheimer's disease to segregate with the A4-amyloid
gene in several European families. Nature : 153-155 (1987) (I.F.:
25.466)
